HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon supplements

This article was originally published in The Rose Sheet

Executive Summary

Global nutritional supplement and vitamin line to bow in 2001 under agreement with Roche. Line extensions will follow every year for the next four years. Under the five-year agreement, Roche Consumer Health will develop the products and assist Avon with marketing activities and regulatory consultation. The yet-to-be-named line will be exclusively marketed through Avon representatives, kiosks and avon.com. By 2001, the supplements will be available in Avon's top 15 markets, including the U.S., U.K., Mexico, Argentina and Brazil. Avon expects its overall line of women's "health and well-being products," including vitamins, will generate $200 mil.-$300 mil. in annual revenues within five years. The company announced its intention to explore other product markets, including supplements, last year (1"The Rose Sheet" April 5, 1999, p. 3)

Global nutritional supplement and vitamin line to bow in 2001 under agreement with Roche. Line extensions will follow every year for the next four years. Under the five-year agreement, Roche Consumer Health will develop the products and assist Avon with marketing activities and regulatory consultation. The yet-to-be-named line will be exclusively marketed through Avon representatives, kiosks and avon.com. By 2001, the supplements will be available in Avon's top 15 markets, including the U.S., U.K., Mexico, Argentina and Brazil. Avon expects its overall line of women's "health and well-being products," including vitamins, will generate $200 mil.-$300 mil. in annual revenues within five years. The company announced its intention to explore other product markets, including supplements, last year (1 (Also see "Avon Will Double Personal Care Sales To $1.5 Bil. By 2005, Jung Predicts" - HBW Insight, 5 Apr, 1999.)).

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007741

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel